Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3318627 | Pancreatology | 2006 | 12 Pages |
Abstract
Background: We have investigated the involvement of cholecystokinin (CCK) receptor subtypes in haemodynamic changes in the pancreas of anaesthetized rats during submaximal and supramaximal stimulation with the CCK analogue, caerulein. Methods: For submaximal stimulation, caerulein (0.4 nmol/kg/h) was infused intravenously, while acute pancreatitis was induced by intraperitoneal injections of high doses of caerulein (3 x 25 nmol/kg). Pancreatic blood flow was measured by hydrogen clearance.Results: Low caerulein doses increased pancreatic blood flow by 26 8 8% and vascular conductance by 24 8 4%. This effect was mimicked by the CCK2 agonist gastrin-17. All effects were abolished by a CCK2 antagonist while a CCK1 antagonist remained inactive. Conversely, amylase output by caerulein was abolished by CCK1 receptor blockade, but not by inhibition of CCK2 receptors. During caerulein-induced pancreatitis, vascular conductance increased by 109 8 26% and remained elevated throughout the experiment; vascular flow initially increased by 62 8 27% and then returned to baseline. The vascular effects were prevented by a CCK2 receptor antagonist, while the induction of pancreatitis was due to CCK-! receptor stimulation.Conclusions: Caerulein increases pancreatic vascular flow via activation of CCK2 receptors. This effect occurs both at submaximal and at supramaximal levels of exocrine stimulation.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Thomas Griesbacher, Irmgard Rainer, Akos Heinemann, Diana Groisman,